Corrigendum: Elexacaftor-Tezacaftor-Ivacaftor treatment reduces abdominal symptoms in cystic fibrosis-early results obtained with the CF-specific CFAbd-Score

[This corrects the article DOI: 10.3389/fphar.2022.877118.].

• Mainz, J. G.
• Zagoya, C.
• Polte, L.
• Naehrlich, L.
• Sasse, L.
• Eickmeier, O.
• Smaczny, C.
• Barucha, A.
• Bechinger, L.
• Duckstein, F.
• Kurzidim, L.
• Eschenhagen, P.
• Caley, L.
• Peckham, D.
• Schwarz, C.